APA (7th ed.) Citation

Taube, J. M., Akturk, G., Angelo, M., Engle, E. L., Gnjatic, S., Greenbaum, S., . . . Bifulco, C. B. (2020). The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation. Journal for immunotherapy of cancer, 8(1), e000155. https://doi.org/10.1136/jitc-2019-000155

Chicago Style (17th ed.) Citation

Taube, Janis M., et al. "The Society for Immunotherapy of Cancer Statement on Best Practices for Multiplex Immunohistochemistry (IHC) and Immunofluorescence (IF) Staining and Validation." Journal for Immunotherapy of Cancer 8, no. 1 (2020): e000155. https://doi.org/10.1136/jitc-2019-000155.

MLA (9th ed.) Citation

Taube, Janis M., et al. "The Society for Immunotherapy of Cancer Statement on Best Practices for Multiplex Immunohistochemistry (IHC) and Immunofluorescence (IF) Staining and Validation." Journal for Immunotherapy of Cancer, vol. 8, no. 1, 2020, p. e000155, https://doi.org/10.1136/jitc-2019-000155.